White House Order Pushes FDA to Fast-Track Serious Mental Health Treatments

The FDA's announcement names specific companies, specific compounds, and specific conditions. Three firms received national priority vouchers for psilocybin studies targeting treatment-resistant depression and major depressive disorder, and for methylone targeting PTSD [1]. DemeRx NB received cleara

Episode metadata supplied by the publisher feed · Published May 7, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

White House Order Pushes FDA to Fast-Track Serious Mental Health Treatments

0:00 15:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of 1nessAgency Insights?

This episode is 15 minutes long.

When was this 1nessAgency Insights episode published?

This episode was published on May 7, 2026.

Can I download this 1nessAgency Insights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!